Portfoliotracker

QuidelOrtho Corporation

QDEL · NASDAQGS · Zdravotnictví Zdravotnické prostředky 0/100 E

10,21 $
▼ −0,53 (−4,93 %)
Predtrh oneskorené o 15 min
Cena z 16. 11. 22:00, stiahnuté 17. 11. 12:53
Ďalšie výsledky–
Ex-dividenda–
Analytici–
Priemer 50 / 200 dní– / –

Cena

Skóre Portfoliotracker0 / 100 Trhová kapitalizácia701 mil. $ P/E– Forward P/E8,2 P/S0,3 P/B0,4 EV/EBITDA2,9 Dividendový výnos– FCF výnos-16,69 % Zisk na akciu-5,39 $ Čistá marža-14,2 % Návratnosť kapitálu ROE-19,3 % Beta0,80 Dlh / vlastný kapitál1,74
52-týždňové rozpätie 9,92 až 35,58
Objem za 3 mesiace1,9 mil.

Financie

Kam smerujú tržby

Načítavam tok výkazu ziskov a strát…

Fundamenty

Načítavam kľúčové čísla…

Insideri, analytici a ľudia

Všetky obchody a zmeny

Načítavam insiderov, analytikov a názory…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

O spoločnosti

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.

Český popis pripravujeme.

Zamestnanci
6 500
Krajina
USA
Koniec fiškálneho roka
1. 1.
Dáta od
1. 2. 1991

Preskúmajte ďalej

Podobné firmy RGENFLGTNVCRDXCMEBS

Graf dňa

Vlastné portfólio, nehnuteľnosti a financie na jednom mieste.

Účet je zadarmo a bez časového obmedzenia. Vaše dáta vidíte len vy, nikto ich nesčíta s ostatnými.

Toto sa ukladá k účtu. Prezerať, počítať a porovnávať môžete ďalej bez prihlásenia.

Vitajte späť

Prihláste sa a pokračujte tam, kde ste skončili.

alebo pokračujte cez

Nemáte účet? Vytvoriť účet zdarma